Sepsis Diagnostics Market
Market Insights on Sepsis Diagnostics covering sales outlook, demand forecast & up-to-date key trends
Sepsis Diagnostics Market Analysis by Product (Blood Culture Media, Assays & Reagents, Instruments, and Software), Technology (Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers), Method (Automated Diagnostics and Conventional Diagnostics), Pathogen (Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others), Test Type, End User, & Region - Forecast to 2022 - 2032
Sepsis Diagnostics Market Outlook
[341 Pages Report] During the assessment period, the worldwide sepsis diagnostics market growth is predicted to rise at a robust CAGR of 9%, from US$ 500 Mn in 2021 to US$ 1.3 Bn by 2032.
“The COVID-19 epidemic boosted sales of sepsis diagnostics devices market to become more popular as the global spread of covid-19 and sepsis cases among covid-19 patients call for quick diagnosis.”
Hospital-acquired infections (HAIs), commonly referred to as nosocomial infections, are a significant source of morbidity and death globally. Urinary tract infections, pneumonia, and sepsis are the most frequently acquired hospital-acquired illnesses (HAIs).
HAIs can result in sepsis in immunocompromised people, the elderly, and those with chronic conditions. Uses of sepsis diagnostics devices are increasing at an annual rate of 8.7% in hospitalised patients in the United States.
Annually, the CDC estimates that more than 1,000,000 cases of sepsis occur among hospitalised patients in the United States (Source: CDC, 2018). With the increasing growth of HAIs globally, demand for sepsis diagnostics devices is projected to expand in the future years.
|
Attributes |
Details |
|
Sepsis Diagnostics Market CAGR (2022 – 2032) |
9% |
|
Sepsis Diagnostics Market |
US$ 500 Mn |
|
Sepsis Diagnostics Market Attraction |
Availability of sophisticated tech to make North America a key market |
Let us know your requirement to get
100% FREE customization
What is the COVID-19 Impact on Sepsis Diagnostics Market?
The sepsis diagnostic market grew impressively with a CAGR of 7.7% by the analysis in 2015. But in 2020, coronavirus infection became widespread, turning into a pandemic and impacting every commercial activity.
All the healthcare and other facilities resources were diverted to control the menace of the pandemic. In such a situation, every other non-emergency healthcare or medical facility was affected to some extent.
But contrary to any other diagnostic services, the sepsis diagnostic market experienced an uncommon boost after it was discovered that multichannel injuries, a symptom of a type of sepsis, development chances were 2% to 5% among Covid-19 patients. The market is now predicted to grow at a CAGR of 9% in the years following the pandemic.
Which Factors Contribute to the Growth of the Sepsis Diagnostics Market?
"The global sepsis diagnostics market is expected to grow due to increased R&D effort. Using a microelectrode biosensor, the sepsis diagnostic devices identify interleukin-6, a protein biomarker, in less than three minutes."
Hospital-acquired infections (HAIs), also known as nosocomial infections, are a leading source of morbidity and death around the world. Urinary tract infections, pneumonia, and sepsis are the most frequent hospital-acquired infections (HAIs).
HAIs can cause sepsis in immunocompromised persons, the elderly, and those suffering from chronic conditions. Sepsis molecular diagnostics among hospitalised patients in the United States increases at an annual rate of 8.7%.
It is predicted that there are more than 1,000,000 cases of sepsis molecular diagnostics among hospitalised patients in the United States each year (Source: CDC, 2018). Furthermore, with the significant growth of HAIs throughout the world, the market for sepsis diagnostic devices is projected to surge in the future years.
What are the Constraints in the Global Sepsis Diagnostics Market?
According to the National Institutes of Health, a molecular diagnostic test can cost between USD 300 and USD 3,000, which is much more expensive than blood culture tests, which can cost as little as USD 28–35.
Although sepsis diagnostics companies are concentrating on developing automated diagnostic instruments for identifying sepsis based on sophisticated technologies such as sepsis molecular diagnostics, government hospitals (particularly in developing countries) and academic research laboratories cannot afford such systems due to funding constraints.
Furthermore, it is becoming a significant hurdle to the market's growth for sepsis diagnostics devices.
What are the Sepsis Diagnostics Market Key Trends & Opportunities?
Sepsis is a complex condition to diagnose, and even a one-minute delay in antibiotic administration increases the risk of mortality in septic shock patients with hypertension by 7.6%. There is a greater need for early sepsis molecular diagnostics to reduce the time between the onset of sepsis and the administration of antibiotics in sepsis patients.
There is an increase in sepsis diagnostic suppliers expanding their product offerings in point-of-care technology. Neonatal sepsis diagnostics diagnose sepsis fast and minimises overall diagnostic turnaround time.
The BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing equipment from BD Company (US) is an automated microbial detection device that may offer a fast diagnosis of sepsis in as little as three hours to the company.
How are Challenges Hindering the Growth of the Sepsis Diagnostics Market?
Sepsis is a potentially fatal illness that must be detected and treated as soon as possible by trained healthcare experts. Unfortunately, the global scarcity of competent professionals is a big problem; barely half of the patients with severe sepsis transferred by the EMS system are accompanied by a paramedic.
The shortage of qualified paramedics has an impact on all phases of patient care, including sepsis awareness, evaluating patients for the presence of sepsis diagnostics devices, and making proper treatment decisions.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystComparative View of Adjacent Sepsis Diagnostics Market
|
Attributes |
Sepsis Diagnostics Market |
In-vitro Diagnostics Quality Control Market |
Allergy Diagnostics Market |
|
CAGR (2022 - 2032) |
9% |
5.5% |
11% |
|
Market Value(2026) |
US$ 770 Mn |
US$ 1.3 Bn |
US$ 8 Bn |
|
Growth Factor |
Rising demand for rapid diagnostic techniques to boost adoption. |
Increasing adoption of third-party quality controls to drive demand. |
Huge economic burden of allergic diseases and increased funding in the development of allergy diagnostics to underpin sales. |
|
Opportunity |
Availability of the latest technologies for the development of novel biomarkers to offer remunerative opportunities. |
Adoption of multi-analyte controls and technological advancements to drive demand. |
Emerging countries such as China and India to offer lucrative opportunities. |
|
Key Trends |
Manufacturers look at Asia Pacific market to expand their operational capacity and reduce their overhead costs. |
Expansions and product releases to be the go-to- inorganic growth strategies. |
Popularity of mHealth for allergy diagnosis offers affordability of diagnosis. |
HAIs, also known as nosocomial infections, are a leading cause of morbidity and mortality in hospitals around the world. Urinary tract infections, pneumonia, and sepsis are the most common hospital-acquired infections (HAIs).
With the rapid rise in HAIs around the world, demand for sepsis diagnostics is expected to increase in the coming years.
Sepsis is a complex condition to diagnose, and even a one-minute delay in antibiotic administration increases the risk of death by 7.6% in septic shock patients with hypertension. As a result, there is a greater need for rapid sepsis diagnostics to reduce antibiotic therapy delays in sepsis patients. Hence, opening up a wide array of sepsis diagnostics market opportunities.
Many sepsis diagnostic companies are expanding their product offerings in point-of-care technology to detect sepsis quickly and cut down on diagnosis time. For example, an automated microbial detection system provides a three-hour, one of the crucial sepsis diagnostics companies, i.e., BD Company's (US) BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing instruments turnaround time for sepsis diagnosis.
The COVID-19 pandemic had a significantly positive impact on the sales of sepsis diagnostics. The emergence of sepsis cases among covid-19 patients is likely to increase demand for rapid diagnosis, resulting in faster adoption of instruments, reagents, and assay kits for sepsis detection.
Researchers are working on a molecular diagnostic that can detect COVID-19 and sepsis while distinguishing between the two. The Hellenic Institute for the Study of Sepsis funded a study. It developed a novel optical biosensor for the early diagnosis of sepsis and severe COVID-19, with funding provided in part by Sanmina Corporation. These recent developments in the sepsis diagnostics market are expected to impact the market's growth positively.
Over the forecast period, sepsis diagnostics market growth is expected to be aided by increasing regulatory approval and introducing technologically advanced diagnostic solutions for sepsis. For example, T2 Biosystems, Inc., a California-based emerging diagnostic solutions company, received FDA-approved sepsis diagnostics for its T2Bacteria Panel, which is designed to detect specific sepsis-causing bacterial pathogens in whole human blood specimens. This is considered to scale up the sepsis diagnostics market size.
Which is the Highly Preferred Method of Sepsis Diagnostics?
Though the automated diagnostic tests are more accurate in predicting the sepsis causing pathogens, given its high price over conventional blood culture methods, it is the major challenge of its wider adoption any quickly. At the same time, the blood culture test costs around US$ 28 to US$ 30, the cost for an automated diagnostic method can be up to US$ 3000. However, increasing healthcare spending in developed and developed regions will boost the demand for automated sepsis diagnosis in the years ahead.
Another reason for predicting a positive growth for the automated molecular sepsis diagnostics market is the shortage of trained healthcare professionals capable of operating conventional sepsis diagnoses.
Which is the Key Technology Segment in the Sepsis Diagnostics Market?
Among all the technologies available for sepsis diagnostics, blood culture still dominates the market worldwide because it is extensive and less costly. Immunoassay technology is also a popular method in healthcare setups and follows blood culture in market share.
Molecular diagnostic technology has several subtypes. Polymerase Chain Reaction (PCR) test became famous in the light of the Covid-19 pandemic for detecting the novel Coronavirus infections. The other established molecular diagnostic technologies are Peptide Nucleic Acid-Fluorescent in situ hybridization, microarrays, DNA sequencing, and syndrome panel-based testing.
Which Pathogen Segment Leads in the Sepsis Diagnostic Market?
As bacterial infections are more common, the bacterial sepsis diagnostics market dominates all the other markets for different pathogen types. Therefore, sepsis diagnostics market analysis is also optimistic for more bacterial sepsis market growth and further dominates the market.
However, it also needs to be noted that after the pandemic of Covid-19, healthcare professionals and researchers are now more concerned about the emergence of any new virus that would be dangerous for mankind like Coronavirus. Therefore, this conundrum will surely bring sufficient opportunities for the viral sepsis diagnostic market.
Which End-user Segment Contributes the most in the Sepsis Diagnostic Market?
Hospitals are the major end users of the Sepsis diagnostics market by the tally of tests of patients coming to the hospital daily. Other than that, pathologies and reference laboratories also undertake a sufficient number of sepsis diagnostic tests on a daily basis and follow the hospital segment by marginal points.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Which Region Holds the Highest Growth Potential in the Sepsis Diagnostics Market?
The North America sepsis diagnostics market is projected to exceed a value of US$ 200 Mn by the year 2026.
Unavailability of highly skilled lab technicians in the developing regions of Asia Pacific regions, the growth of the Sepsis diagnostic market was not impressive earlier. But the increasing number of new product approvals and launches has provided new life to the market of this region.
The rising population in the Asia Pacific excluding Japan (APEJ) region and their improving living standards also boost the region's healthcare spending. This has, in turn, provided immense opportunity for the emerging market of septic diagnostic services in these regions.
Also, as the average year of the global population is growing, it will surely raise the demand for sepsis diagnostics devices for sepsis cure-all across the globe equally.
How Intense is the Competition in the Sepsis Diagnostics Market?
The Major Players in the global sepsis diagnostic market are Abbott, Becton, Dickinson, and Company, bioMérieux SA, Bruker Corporation, F. Hoffmann-LA Roche Ltd, Immunexpress Inc., Diasorin, Response Biomedical Corp., T2 Biosystems, Inc., and Thermo Fisher Scientific.
Various sepsis diagnostic companies are investing in research and development for new methods and equipment to reduce the time taken by the cumbersome preexisting sepsis diagnostic process.
Because of the limited reach of sepsis diagnostic services except in North America, significant players in this market are getting into agreements for collaborations and partnerships for expanding their market outreach.
Major Developments in Sepsis Diagnostics Market:
- Immunexpress launched a one-hour molecular diagnostic test for sepsis named rapid SeptiCyte in 2020. It is a fully-integrated test that delivers quick results based on the immune response.
- Biofire Mycoplasma is another fully automated test that can deliver results within hours. This rapid and easy to use a molecular diagnostic test to detect mycoplasma in biotherapeutics products was introduced by a French biotechnology Company named BioMeriux SA in the year 2020.
- To make its rapid sepsis diagnostic system more prevalent among patients in other regional markets, Cytovale Inc. has signed a partnership with the Biomedical Advanced Research and Development Authority (BARDA) in 2020. This system is particularly beneficial for patients with the chance of respiratory illness.
Key Segments
By Product:
- Blood Culture Media
- Assays & Reagents
- Instruments, and Software
By Technology:
- Blood Culture
- Immunoassays
- Molecular Diagnostics
- Flow Cytometry
- Microfluidics
- Biomarkers
By Method:
- Automated Diagnostics
- Conventional Diagnostics
By Pathogen:
- Bacterial Sepsis
- Fungal Sepsis
- Viral Sepsis
- Others
By Test Type:
- Laboratory Tests
- Point-of-Care Tests
By End User:
- Hospitals and Specialty Clinics
- Pathology & Reference Laboratories
- Research Laboratories & Academic Institutes
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Frequently Asked Questions
The sepsis diagnostics market is predicted to expand at a 9% CAGR by 2032.
The sepsis molecular diagnostics market was valued at $500 million in 2021.
The sepsis molecular diagnostics market is expected to hit US$1.3 Bn by 2032.
The adoption trend of sepsis diagnostics devices is anticipated to remain the highest in North America.
The sepsis diagnostics market is estimated to reach US$ 770 Mn by 2026.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Sepsis Diagnostics Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Componentulation and Product Development Trends
4. Market Background
4.1. Sepsis Diagnostics Market By Country, US$ Mn
4.2. Sepsis Diagnostics Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Sepsis Diagnostics Market Growth
4.5.3. Sepsis Diagnostics Adoption Rate, by Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Sepsis Diagnostics Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Sepsis Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Sepsis Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Mn) and Analysis By Product, 2015-2021
8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Product, 2022-2032
8.3.1. Blood Culture Media
8.3.2. Assays & Reagents
8.3.3. Instruments
8.3.4. Software
8.4. Market Attractiveness Analysis By Product
9. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Technology
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn) and Analysis By Technology, 2015-2021
9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Technology, 2022-2032
9.3.1. Blood Culture
9.3.2. Immunoassays
9.3.3. Molecular Diagnostics
9.3.3.1. PCR
9.3.3.2. Peptide Nucleic Acid-Fluorescent In Situ Hybridization
9.3.3.3. Microarrays
9.3.3.4. DNA Sequencing
9.3.3.5. Syndromic Panel-Based Testing
9.3.4. Flow Cytometry
9.3.5. Microfluidics
9.3.6. Biomarkers
9.4. Market Attractiveness Analysis By Technology
10. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Method
10.1.1. 10.1.Introduction / Key Findings
10.1.2. 10.2.Historical Market Value (US$ Mn) and Analysis By Method, 2015-2021
10.1.3. 10.3.Current and Future Market Value (US$ Mn) and Analysis and Forecast By Method, 2022-2032
10.1.3.1. 10.3.1. Automated Diagnostics
10.1.3.2. 10.3.2. Conventional Diagnostics
10.1.4. 10.4.Market Attractiveness Analysis By Method
11. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Pathogen
11.1.1. 11.1.Introduction / Key Findings
11.1.2. 11.2.Historical Market Value (US$ Mn) and Analysis By Pathogen, 2015-2021
11.1.3. 11.3.Current and Future Market Value (US$ Mn) and Analysis and Forecast By Pathogen, 2022-2032
11.1.3.1. 11.3.1. Bacterial Sepsis
11.1.3.2. 11.3.2. Fungal Sepsis
11.1.3.3. 11.3.3. Viral Sepsis
11.1.3.4. 11.3.4. Other Pathogen
11.1.4. 11.4.Market Attractiveness Analysis By Pathogen
12. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type
12.1.1. 12.1.Introduction / Key Findings
12.1.2. 12.2.Historical Market Value (US$ Mn) and Analysis By Test Type, 2015-2021
12.1.3. 12.3.Current and Future Market Value (US$ Mn) and Analysis and Forecast By Test Type, 2022-2032
12.1.3.1. 12.3.1. Laboratory Tests
12.1.3.2. 12.3.2. Point-of-Care Tests
12.1.4. 12.4.Market Attractiveness Analysis By Test Type
13. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End-User
13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
13.3.1. Hospitals and Specialty Clinics
13.3.2. Pathology & Reference Laboratories
13.3.3. Research Laboratories & Academic Institutes
13.4. Market Attractiveness Analysis By Region
14. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region
14.1. Introduction
14.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
14.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. Asia Pacific
14.3.5. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
15.3.1.1. 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country
15.3.1.1.1. 15.4.1.1. U.S.
15.3.1.1.2. 15.4.1.2. Canada
15.3.1.2. 15.4.2. By Method
15.3.1.3. 15.4.3. By Product
15.3.1.4. 15.4.4. By Technology
15.3.1.5. 15.4.5. By Pathogen
15.3.1.6. 15.4.6. By Test Type
15.3.1.7. 15.4.7. By End-User
15.4. Market Attractiveness Analysis
15.4.1.1. 15.5.1. By Country
15.4.1.2. 15.5.2. By Method
15.4.1.3. 15.5.3. By Product
15.4.1.4. 15.5.4. By Technology
15.4.1.5. 15.5.5. By Pathogen
15.4.1.6. 15.5.6. By Test Type
15.4.1.7. 15.5.7. By End-User
16. Latin America Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Brazil
16.4.1.2. Mexico
16.4.1.3. Rest of Latin America
16.4.2. By Method
16.4.3. By Product
16.4.4. By Technology
16.4.5. By Pathogen
16.4.6. By Test Type
16.4.7. By End-User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Method
16.5.3. By Product
16.5.4. By Technology
16.5.5. By Pathogen
16.5.6. By Test Type
16.5.7. By End-User
17. Europe Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. Germany
17.4.1.2. France
17.4.1.3. U.K.
17.4.1.4. Italy
17.4.1.5. Benelux
17.4.1.6. Russia
17.4.1.7. Rest of Europe
17.4.2. By Method
17.4.3. By Product
17.4.4. By Technology
17.4.5. By Pathogen
17.4.6. By Test Type
17.4.7. By End-User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Method
17.5.3. By Product
17.5.4. By Technology
17.5.5. By Pathogen
17.5.6. By Test Type
17.5.7. By End-User
18. Asia Pacific Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.1.4. Rest of Asia Pacific
18.4.2. By Method
18.4.3. By Product
18.4.4. By Technology
18.4.5. By Pathogen
18.4.6. By Test Type
18.4.7. By End-User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Method
18.5.3. By Product
18.5.4. By Technology
18.5.5. By Pathogen
18.5.6. By Test Type
18.5.7. By End-User
19. Middle East and Africa Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
19.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
19.4.1. By Country
19.4.1.1. GCC Countries
19.4.1.2. South Africa
19.4.1.3. Turkey
19.4.1.4. Rest of Middle East and Africa
19.4.2. By Method
19.4.3. By Product
19.4.4. By Technology
19.4.5. By Pathogen
19.4.6. By Test Type
19.4.7. By End-User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Method
19.5.3. By Product
19.5.4. By Technology
19.5.5. By Pathogen
19.5.6. By Test Type
19.5.7. By End-User
20. Key Countries Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. US Sepsis Diagnostics Market Analysis
20.2.1. Value Proportion Analysis by Market Taxonomy
20.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.2.2.1. By Method
20.2.2.2. By Product
20.2.2.3. By Technology
20.2.2.4. By Pathogen
20.2.2.5. By Test Type
20.2.2.6. By End-User
20.3. Canada Sepsis Diagnostics Market Analysis
20.3.1. Value Proportion Analysis by Market Taxonomy
20.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.3.2.1. By Method
20.3.2.2. By Product
20.3.2.3. By Technology
20.3.2.4. By Pathogen
20.3.2.5. By Test Type
20.3.2.6. By End-User
20.4. Mexico Sepsis Diagnostics Market Analysis
20.4.1. Value Proportion Analysis by Market Taxonomy
20.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.4.2.1. By Method
20.4.2.2. By Product
20.4.2.3. By Technology
20.4.2.4. By Pathogen
20.4.2.5. By Test Type
20.4.2.6. By End-User
20.5. Brazil Sepsis Diagnostics Market Analysis
20.5.1. Value Proportion Analysis by Market Taxonomy
20.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.5.2.1. By Method
20.5.2.2. By Product
20.5.2.3. By Technology
20.5.2.4. By Pathogen
20.5.2.5. By Test Type
20.5.2.6. By End-User
20.6. Germany Sepsis Diagnostics Market Analysis
20.6.1. Value Proportion Analysis by Market Taxonomy
20.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.6.2.1. By Method
20.6.2.2. By Product
20.6.2.3. By Technology
20.6.2.4. By Pathogen
20.6.2.5. By Test Type
20.6.2.6. By End-User
20.7. France Sepsis Diagnostics Market Analysis
20.7.1. Value Proportion Analysis by Market Taxonomy
20.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.7.2.1. By Method
20.7.2.2. By Product
20.7.2.3. By Technology
20.7.2.4. By Pathogen
20.7.2.5. By Test Type
20.7.2.6. By End-User
20.8. Italy Sepsis Diagnostics Market Analysis
20.8.1. Value Proportion Analysis by Market Taxonomy
20.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.8.2.1. By Method
20.8.2.2. By Product
20.8.2.3. By Technology
20.8.2.4. By Pathogen
20.8.2.5. By Test Type
20.8.2.6. By End-User
20.9. Russia Sepsis Diagnostics Market Analysis
20.9.1. Value Proportion Analysis by Market Taxonomy
20.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.9.2.1. By Method
20.9.2.2. By Product
20.9.2.3. By Technology
20.9.2.4. By Pathogen
20.9.2.5. By Test Type
20.9.2.6. By End-User
20.10. UK Sepsis Diagnostics Market Analysis
20.10.1. Value Proportion Analysis by Market Taxonomy
20.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.10.2.1. By Method
20.10.2.2. By Product
20.10.2.3. By Technology
20.10.2.4. By Pathogen
20.10.2.5. By Test Type
20.10.2.6. By End-User
20.11. Benelux Sepsis Diagnostics Market Analysis
20.11.1. Value Proportion Analysis by Market Taxonomy
20.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.11.2.1. By Method
20.11.2.2. By Product
20.11.2.3. By Technology
20.11.2.4. By Pathogen
20.11.2.5. By Test Type
20.11.2.6. By End-User
20.12. China Sepsis Diagnostics Market Analysis
20.12.1. Value Proportion Analysis by Market Taxonomy
20.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.12.2.1. By Method
20.12.2.2. By Product
20.12.2.3. By Technology
20.12.2.4. By Pathogen
20.12.2.5. By Test Type
20.12.2.6. By End-User
20.13. Japan Sepsis Diagnostics Market Analysis
20.13.1. Value Proportion Analysis by Market Taxonomy
20.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.13.2.1. By Method
20.13.2.2. By Product
20.13.2.3. By Technology
20.13.2.4. By Pathogen
20.13.2.5. By Test Type
20.13.2.6. By End-User
20.14. South Korea Sepsis Diagnostics Market Analysis
20.14.1. Value Proportion Analysis by Market Taxonomy
20.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.14.2.1. By Method
20.14.2.2. By Product
20.14.2.3. By Technology
20.14.2.4. By Pathogen
20.14.2.5. By Test Type
20.14.2.6. By End-User
20.15. GCC Countries Sepsis Diagnostics Market Analysis
20.15.1. Value Proportion Analysis by Market Taxonomy
20.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.15.2.1. By Method
20.15.2.2. By Product
20.15.2.3. By Technology
20.15.2.4. By Pathogen
20.15.2.5. By Test Type
20.15.2.6. By End-User
20.16. South Africa Sepsis Diagnostics Market Analysis
20.16.1. Value Proportion Analysis by Market Taxonomy
20.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.16.2.1. By Method
20.16.2.2. By Product
20.16.2.3. By Technology
20.16.2.4. By Pathogen
20.16.2.5. By Test Type
20.16.2.6. By End-User
20.17. Turkey Sepsis Diagnostics Market Analysis
20.17.1. Value Proportion Analysis by Market Taxonomy
20.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
20.17.2.1. By Method
20.17.2.2. By Product
20.17.2.3. By Technology
20.17.2.4. By Pathogen
20.17.2.5. By Test Type
20.17.2.6. By End-User
20.17.3. Competition Landscape and Player Concentration in the Country
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1. By Regional footprint of Players
21.4.2. Product footprint by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. BIOMÉRIEUX
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Strategy Overview
22.3.2. BECTON, DICKINSON, AND COMPANY
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Strategy Overview
22.3.3. DANAHER CORPORATION
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Strategy Overview
22.3.4. T2 BIOSYSTEMS
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Strategy Overview
22.3.5. LUMINEX
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Strategy Overview
22.3.6. F. HOFFMANN-LA ROCHE AG
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Strategy Overview
22.3.7. THERMO FISHER SCIENTIFIC
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Strategy Overview
22.3.8. BRUKER CORPORATION
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Strategy Overview
22.3.9. ABBOTT LABORATORIES
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Strategy Overview
22.3.10. QUIDEL CORPORATION
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Strategy Overview
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Global Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021
Table 2: Global Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032
Table 3: Global Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021
Table 4: Global Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032
Table 5: Global Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021
Table 6: Global Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032
Table 7: Global Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021
Table 8: Global Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032
Table 9: Global Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021
Table 10: Global Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032
Table 11: Global Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021
Table 12: Global Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032
Table 13: Global Sepsis Diagnostics Market, By Region, 2015 – 2021
Table 14: Global Sepsis Diagnostics Market, By Region, 2022 – 2032
Table 15: North America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021
Table 16: North America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032
Table 17: North America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021
Table 18: North America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032
Table 19: North America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021
Table 20: North America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032
Table 21: North America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021
Table 22: North America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032
Table 23: North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021
Table 24: North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032
Table 25: North America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021
Table 26: North America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032
Table 27: North America Sepsis Diagnostics Market, By Country, 2015 – 2021
Table 28: North America Sepsis Diagnostics Market, By Country, 2022 – 2032
Table 29: Latin America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021
Table 30: Latin America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032
Table 31: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021
Table 32: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032
Table 33: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021
Table 34: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032
Table 35: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021
Table 36: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032
Table 37: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021
Table 38: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032
Table 39: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021
Table 40: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032
Table 41: Latin America Sepsis Diagnostics Market, By Country, 2015 – 2021
Table 42: Latin America Sepsis Diagnostics Market, By Country, 2022 – 2032
Table 43: Europe Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021
Table 44: Europe Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032
Table 45: Europe Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021
Table 46: Europe Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032
Table 47: Europe Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021
Table 48: Europe Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032
Table 49: Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021
Table 50: Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032
Table 51: Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021
Table 52: Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032
Table 53: Europe Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021
Table 54: Europe Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032
Table 55: Europe Sepsis Diagnostics Market, By Country, 2015 – 2021
Table 56: Europe Sepsis Diagnostics Market, By Country, 2022 – 2032
Table 57: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021
Table 58: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032
Table 59: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021
Table 60: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032
Table 61: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021
Table 62: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032
Table 63: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021
Table 64: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032
Table 65: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021
Table 66: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032
Table 67: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021
Table 68: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032
Table 69: Asia Pacific Sepsis Diagnostics Market, By Country, 2015 – 2021
Table 70: Asia Pacific Sepsis Diagnostics Market, By Country, 2022 – 2032
Table 71: MEA Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021
Table 72: MEA Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032
Table 73: MEA Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021
Table 74: MEA Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032
Table 75: MEA Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021
Table 76: MEA Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032
Table 77: MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021
Table 78: MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032
Table 79: MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021
Table 80: MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032
Table 81: MEA Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021
Table 82: MEA Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032
Table 83: MEA Sepsis Diagnostics Market, By Country, 2015 – 2021
Table 84: MEA Sepsis Diagnostics Market, By Country, 2022 – 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Sepsis Diagnostics Market Share,By End-User, 2022 & 2032
Figure 4: Global Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032
Figure 5: Global Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032
Figure 6: Global Sepsis Diagnostics Market Share, By Product, 2022 & 2032
Figure 7: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 8: Global Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032
Figure 9: Global Sepsis Diagnostics Market Share, By Technology, 2022 & 2032
Figure 10: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 11: Global Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 12: Global Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032
Figure 13: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032
Figure 14: Global Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032
Figure 15: Global Sepsis Diagnostics Market Share, By Method, 2022 & 2032
Figure 16: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 17: Global Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032
Figure 18: Global Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032
Figure 19: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032
Figure 20: Global Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032
Figure 21: Global Sepsis Diagnostics Market Share, By Region, 2022 & 2032
Figure 22: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 23: Global Sepsis Diagnostics Market Attractiveness Index, By Region – 2022-2032
Figure 24: North America Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 25: North America Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 26: North America Sepsis Diagnostics Market Share,By End-User, 2022 & 2032
Figure 27: North America Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032
Figure 28: North America Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032
Figure 29: North America Sepsis Diagnostics Market Share, By Product, 2022 & 2032
Figure 30: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 31: North America Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032
Figure 32: North America Sepsis Diagnostics Market Share, By Technology, 2022 & 2032
Figure 33: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 34: North America Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 35: North America Sepsis Diagnostics Market Share, By Method, 2022 & 2032
Figure 36: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 37: North America Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032
Figure 38: North America Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032
Figure 39: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032
Figure 40: North America Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032
Figure 41: North America Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032
Figure 42: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032
Figure 43: North America Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032
Figure 44: North America Sepsis Diagnostics Market Share, By Country, 2022 & 2032
Figure 45: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 46: North America Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032
Figure 47: Latin America Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 48: Latin America Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 49: Latin America Sepsis Diagnostics Market Share,By End-User, 2022 & 2032
Figure 50: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032
Figure 51: Latin America Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032
Figure 52: Latin America Sepsis Diagnostics Market Share, By Product, 2022 & 2032
Figure 53: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 54: Latin America Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032
Figure 55: Latin America Sepsis Diagnostics Market Share, By Technology, 2022 & 2032
Figure 56: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 57: Latin America Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 58: Latin America Sepsis Diagnostics Market Share, By Method, 2022 & 2032
Figure 59: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 60: Latin America Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032
Figure 61: Latin America Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032
Figure 62: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032
Figure 63: Latin America Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032
Figure 64: Latin America Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032
Figure 65: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032
Figure 66: Latin America Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032
Figure 67: Latin America Sepsis Diagnostics Market Share, By Country, 2022 & 2032
Figure 68: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 69: Latin America Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032
Figure 70: Europe Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 71: Europe Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 72: Europe Sepsis Diagnostics Market Share,By End-User, 2022 & 2032
Figure 73: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032
Figure 74: Europe Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032
Figure 75: Europe Sepsis Diagnostics Market Share, By Product, 2022 & 2032
Figure 76: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 77: Europe Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032
Figure 78: Europe Sepsis Diagnostics Market Share, By Technology, 2022 & 2032
Figure 79: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 80: Europe Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 81: Europe Sepsis Diagnostics Market Share, By Method, 2022 & 2032
Figure 82: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 83: Europe Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032
Figure 84: Europe Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032
Figure 85: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032
Figure 86: Europe Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032
Figure 87: Europe Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032
Figure 88: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032
Figure 89: Europe Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032
Figure 90: Europe Sepsis Diagnostics Market Share, By Country, 2022 & 2032
Figure 91: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 92: Europe Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032
Figure 93: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 94: Asia Pacific Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 95: Asia Pacific Sepsis Diagnostics Market Share,By End-User, 2022 & 2032
Figure 96: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032
Figure 97: Asia Pacific Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032
Figure 98: Asia Pacific Sepsis Diagnostics Market Share, By Product, 2022 & 2032
Figure 99: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 100: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032
Figure 101: Asia Pacific Sepsis Diagnostics Market Share, By Technology, 2022 & 2032
Figure 102: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 103: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 104: Asia Pacific Sepsis Diagnostics Market Share, By Method, 2022 & 2032
Figure 105: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 106: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032
Figure 107: Asia Pacific Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032
Figure 108: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032
Figure 109: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032
Figure 110: Asia Pacific Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032
Figure 111: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032
Figure 112: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032
Figure 113: Asia Pacific Sepsis Diagnostics Market Share, By Country, 2022 & 2032
Figure 114: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 115: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032
Figure 116: MEA Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 117: MEA Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 118: MEA Sepsis Diagnostics Market Share,By End-User, 2022 & 2032
Figure 119: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032
Figure 120: MEA Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032
Figure 121: MEA Sepsis Diagnostics Market Share, By Product, 2022 & 2032
Figure 122: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 123: MEA Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032
Figure 124: MEA Sepsis Diagnostics Market Share, By Technology, 2022 & 2032
Figure 125: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 126: MEA Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 127: MEA Sepsis Diagnostics Market Share, By Method, 2022 & 2032
Figure 128: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 129: MEA Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032
Figure 130: MEA Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032
Figure 131: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032
Figure 132: MEA Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032
Figure 133: MEA Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032
Figure 134: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032
Figure 135: MEA Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032
Figure 136: MEA Sepsis Diagnostics Market Share, By Country, 2022 & 2032
Figure 137: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 138: MEA Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
